News | July 02, 2022
Lonza to invest 500 mn in commercial drug product fill & finish facility
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Lacosamide Injection is used to treat partial-onset seizures.
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
It is a two dose vaccine to be administered intramuscularly at 28 days apart
Subscribe To Our Newsletter & Stay Updated
